US1690175A - Method of preparing tannic-acid compositions - Google Patents

Method of preparing tannic-acid compositions Download PDF

Info

Publication number
US1690175A
US1690175A US86061A US8606126A US1690175A US 1690175 A US1690175 A US 1690175A US 86061 A US86061 A US 86061A US 8606126 A US8606126 A US 8606126A US 1690175 A US1690175 A US 1690175A
Authority
US
United States
Prior art keywords
mass
compound
distilled water
acid compositions
glycerin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US86061A
Inventor
Russell S Paterson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US86061A priority Critical patent/US1690175A/en
Application granted granted Critical
Publication of US1690175A publication Critical patent/US1690175A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof

Definitions

  • My invention relates to a, medical compound and method of making the same.
  • the object of myinvention is to provide a medical compound for internal use by in- 5 jection and one that is especially adapted to be used in the treatment of gonorrhea, gleet and their complications.
  • the ingredients of the compound are tannic acid, zinc oxide, glycerin and Water and the m preparation may be made in two strengths increasing or decreasing the amount of tannic acid and zinc oxide used.
  • a full strength compound consists of:
  • a medium strength compound is composed Tannic acid 2 drams Zinc oxide 2 drams -Glycerin 2 fluid ounces 2 Distilled water 5 fluid ounces
  • the preferred method of making the medical compound is as follows:
  • Tannic acid and zinc oxide are thoroughly ground and mixed to other by stirring for a time. Glycerin is then 7 considerable length 0 added and the same stirred until the ingredients are thoroughly mixed; a small portion of distilled water is then added and the whole I mass given two or three stirs in the same direction and the mass allowed to stand unt l- The hardened mass thus formed is it sets. redissolved in distilled water to produce a compound by volume of approximately Application filed February 4, 1926. Serial No. 86,061.
  • the medicine is used as an urethral injection from two to four times a day, using it four timesa day at the start and gradually 7 cutting the injection to two as the gonorrhea gets better. It can be injected with any ordinary urethral syringe bythe patient himself or can be injected by the doctor.
  • the dosage will vary according to the size 39 of the urethra. Enough is injected to fill the urethra until the patient can just feel the solution entering the bladder and this as a rule takes from two to three drams.
  • What I claim is 1.
  • the method herein described of making a medical compound from tannic acid, zinc oxide, glycerin and distilled water, which 9 consists in grinding and mixing together tannic acid and zinc oxide, then mixing glycerin with the compound produced, then addagain thoroughly stirring the ingredients then adding distilled Water and slightly stir ring the water into the mass and allowing the mass to harden and then redissolving the hardened mass in distilled water.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dental Preparations (AREA)

Description

Patented Nov. 6, 1928.
RUSSELL S. PATEBSON,
OF MOBILE, ALABAMA.
METHOD OF PREPARING TANNIG-ACID COMPOSITIONS.
Drawing.
My invention relates to a, medical compound and method of making the same.
The object of myinvention is to provide a medical compound for internal use by in- 5 jection and one that is especially adapted to be used in the treatment of gonorrhea, gleet and their complications.
The ingredients of the compound are tannic acid, zinc oxide, glycerin and Water and the m preparation may be made in two strengths increasing or decreasing the amount of tannic acid and zinc oxide used.
A full strength compound consists of:
'lannic acid r.. 2 drams Zinc oxide 2 drains Glycerin 2fluid ounces Distilled water 5 6/16 fluid ounces 6 A medium strength compound is composed Tannic acid 2 drams Zinc oxide 2 drams -Glycerin 2 fluid ounces 2 Distilled water 5 fluid ounces The preferred method of making the medical compound is as follows:
. Tannic acid and zinc oxide are thoroughly ground and mixed to other by stirring for a time. Glycerin is then 7 considerable length 0 added and the same stirred until the ingredients are thoroughly mixed; a small portion of distilled water is then added and the whole I mass given two or three stirs in the same direction and the mass allowed to stand unt l- The hardened mass thus formed is it sets. redissolved in distilled water to produce a compound by volume of approximately Application filed February 4, 1926. Serial No. 86,061.
I add 2 fluid ounces of glycerin and the Whole i mass is stirred thoroughly. I then add 1 8/16 fluid ounces of distilled water and. give the mass two or three stirs in the same direction. The mass is then let stand until it sets and after it has set, it is redissolved in substantially 3 and 14/16 fluid ounces of distilled water, which produces a'compound by volume of approximately 8 ounces. In carrying out the method to produce the medium strength, ounce of tannic acid is mixed with ounce of zinc oxide by thoroughly grinding and stirring the two to- I gether and to this mixture 2 fluid ounces of glycerin is added and the whole mass stirred thoroughly. I then add 1% fluid ounces of 05 distilled water and stir the same two or three timesin one direction only and the mass thus formed is allowed to stand until it sets or hardens. After-the mass has hardened, it is redissolved in 5 fluid ounces of distilled 7 water, which produces a compound'by volume of approximately 8 ounces.
The medicine is used as an urethral injection from two to four times a day, using it four timesa day at the start and gradually 7 cutting the injection to two as the gonorrhea gets better. It can be injected with any ordinary urethral syringe bythe patient himself or can be injected by the doctor.
The dosage will vary according to the size 39 of the urethra. Enough is injected to fill the urethra until the patient can just feel the solution entering the bladder and this as a rule takes from two to three drams.
While I have described a method of producing a medical compound for the treatment of certain diseases, it is, of course, understood that the same can be used for treating kindred diseases and that the proportions can be varied without departing from 'thespirit of 9 my invention.
What I claim is 1. The method herein described of making a medical compound from tannic acid, zinc oxide, glycerin and distilled water, which 9 consists in grinding and mixing together tannic acid and zinc oxide, then mixing glycerin with the compound produced, then addagain thoroughly stirring the ingredients then adding distilled Water and slightly stir ring the water into the mass and allowing the mass to harden and then redissolving the hardened mass in distilled water.
In testimony whereof I hereunto allix my signature.
RUSSELL S. FATE ihUN.
US86061A 1926-02-04 1926-02-04 Method of preparing tannic-acid compositions Expired - Lifetime US1690175A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US86061A US1690175A (en) 1926-02-04 1926-02-04 Method of preparing tannic-acid compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86061A US1690175A (en) 1926-02-04 1926-02-04 Method of preparing tannic-acid compositions

Publications (1)

Publication Number Publication Date
US1690175A true US1690175A (en) 1928-11-06

Family

ID=22195997

Family Applications (1)

Application Number Title Priority Date Filing Date
US86061A Expired - Lifetime US1690175A (en) 1926-02-04 1926-02-04 Method of preparing tannic-acid compositions

Country Status (1)

Country Link
US (1) US1690175A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2702914A1 (en) * 1976-01-23 1977-09-15 Univ Missouri INJECTABLE STERILIZER FOR MALE ANIMALS FOR SELECTIVE CONTROL OF THE TEST FUNCTION
US4156427A (en) * 1976-01-23 1979-05-29 The Curators Of The University Of Missouri Injectable male animal sterilant for selectively controlling the function of testes
US4339438A (en) * 1976-01-23 1982-07-13 The Curators Of The University Of Missouri Injectable male animal sterilant for selectively controlling the function of testes

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2702914A1 (en) * 1976-01-23 1977-09-15 Univ Missouri INJECTABLE STERILIZER FOR MALE ANIMALS FOR SELECTIVE CONTROL OF THE TEST FUNCTION
US4156427A (en) * 1976-01-23 1979-05-29 The Curators Of The University Of Missouri Injectable male animal sterilant for selectively controlling the function of testes
US4339438A (en) * 1976-01-23 1982-07-13 The Curators Of The University Of Missouri Injectable male animal sterilant for selectively controlling the function of testes

Similar Documents

Publication Publication Date Title
US4118480A (en) Pharmaceutical preparation for treating hemorrhoids and anal fissures
US1690175A (en) Method of preparing tannic-acid compositions
Mao et al. Usefulness of contrast‐enhanced ultrasound in the diagnosis of biliary leakage following T‐tube removal
Ashworth Peyronie's disease
EP1337223A2 (en) Dental compounds with reduced temperature sensitivity
US3644620A (en) Antiphlogistic
JP2008019246A (en) Dental cement
US1433979A (en) Preparation for the treatment of pyorrhea
Rutherford V.—On the Physiological Actions of Drugs on the Secretion of Bile
US1183055A (en) Bromin solution.
Eddahabi et al. The choice of the base for the creation of rectal suppositories for the treatment of hemorrhoid
CN104096027B (en) It is a kind of to treat emplastrum of mastosis and preparation method thereof
CN108403721A (en) Water stone acne cream and preparation method thereof
US242792A (en) Medical compound
US238581A (en) Bitters
Wagner Investigations concerning the Influence of Roentgen Irradiation on the Resistance to Cancer in White Mice: A Preliminary Communication
CN115154412A (en) A kind of repairing antibacterial gel and preparation method thereof
US1540922A (en) Agglomerated material and process for making the same
US1560075A (en) Waterproof paint
US1404673A (en) Preparations of medicinal substances and method of making the same
US1569202A (en) Medical preparation
Chamberlain COMPOUND GELATINE MEDICATED TENTS
Hodges Bronzed Diabetes In A Woman
US1314076A (en) Medicated salt brick
CN101829177B (en) Medicine composition for postoperative wound restoration and preparation method thereof